Table 1.
Demographics and genetic testing results
| Criteria | Number (%) | |
|---|---|---|
| Gender | Male | 32 (31.4) |
| Female | 70 (68.6) | |
| Ethnicity | White/Caucasian (non-Jewish) | 89 (87.3) |
| White/Caucasian (Jewish) | 12 (11.8) | |
| Asian | 1 (1.0) | |
| Age | Mean (Range) | |
| Overall | 56 (35-78y) | |
| Male | 57 (37-78y) | |
| Female | 56 (35-72y) | |
| Family history | 1 FDR (plus 1 or more SDR) | 38 (37.3) |
| 2 FDR (+/− 1 or more SDR) | 30 (29.4) | |
| 3 FDR (+/− 1 or more SDR) | 11 (10.8) | |
| BRCA2 (plus 1 or more relative with PC) | 22 (21.6) | |
| Clinical diagnosis of PJS | 1 (1.0) | |
| Genetic testing and previous malignancy | ||
| Not tested | Total | 31 (30.4) |
| (including PJS participant) | None | 30 (29.4) |
| Breast | 1 (1.0) | |
| No mutation identified | Total | 49 (48.0) |
| (Self or close affected relative) | Nil cancer | 42 (41.2) |
| Thyroid | 1 (1.0) | |
| Breast | 5 (4.9) | |
| Melanoma | 1 (1.0) | |
| BRCA2 carrier | Total | 22 (21.6) |
| Nil cancer | 10 (9.8) | |
| Breast | 5 (4.9) | |
| Breast – Bilateral | 4 (3.9) | |
| Prostate | 1 (1.0) | |
| Prostate/Brain tumour | 1 (1.0) | |
| Melanoma | 1 (1.0) | |
| Smoking statusa | Never smoked | 56 (55.4) |
| Previous smoker | 41 (40.6) | |
| Current smoker | 4 (4.0) | |
| Alcohol consumptionb | Non-drinker | 17 (17.0) |
| Social drinker | 19 (19.0) | |
| Weekly drinker | 36 (36.0) | |
| Daily drinker | 28 (28.0) | |
a one data point not declared; b two data points not declared